Absence of carcinogenic effects of estradiol mustard (NSC-112259) in rats
- PMID: 136827
- DOI: 10.1007/BF00284377
Absence of carcinogenic effects of estradiol mustard (NSC-112259) in rats
Abstract
Estradiol mustard (NSC 112259) was subcutaneously injected to female Sprague-Dawley-rats in weekly doses of 10 and 20 mg/kg up to a total dose (Dmax) of 500 or 760 mg/kg respectively. Treatments reduced significantly the mean survival time. No carcinogenic properties were observed. Most of the estrogen mustard treated animals died from ovarian abscesses or peritonitis following pyometras. Toxic injuries were attributed to the chronical estrogenic stimulus.
Similar articles
-
Effects of cancer chemotherapeutic agents on endocrine organs and serum levels of estrogens, progesterone, prolactin, and luteinizing hormone.Cancer Res. 1975 Aug;35(8):1975-80. Cancer Res. 1975. PMID: 125149
-
Toxicology and carcinogenesis studies of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).Natl Toxicol Program Tech Rep Ser. 2008 Jan;(545):1-240. Natl Toxicol Program Tech Rep Ser. 2008. PMID: 18685716
-
Toxicity in beagle dogs of three alkylating esters with antitumor activity: phenesterin (NSC-104469), estradiol mustard (NSC-112259), and dehydroepiandrosterone mustard (NSC-12121).Cancer Chemother Rep 3. 1973 Jan;4(1):85-95. Cancer Chemother Rep 3. 1973. PMID: 4267410 No abstract available.
-
Oestradiol mustard.IARC Monogr Eval Carcinog Risk Chem Man. 1975;9:217-21. IARC Monogr Eval Carcinog Risk Chem Man. 1975. PMID: 791835 Review. No abstract available.
-
Nitrogen mustard N-oxide (hydrochloride).IARC Monogr Eval Carcinog Risk Chem Man. 1975;9:209-16. IARC Monogr Eval Carcinog Risk Chem Man. 1975. PMID: 791834 Review. No abstract available.